{"id":"W2041814933","doi":"10.1097/jto.0b013e3181a94b08","title":"Intermittent Erlotinib in Combination with Pemetrexed: Phase I Schedules Designed to Achieve Pharmacodynamic Separation","year":2009,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"Genentech; Eli Lilly and Company","keywords":"Medicine; Pemetrexed; Erlotinib; Pharmacodynamics; Separation (statistics); Pharmacology; Oncology; Internal medicine; Pharmacokinetics; Cancer; Chemotherapy; Machine learning; Epidermal growth factor receptor; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008006327,0.0006787873,0.001234459,0.0005758642,0.0003356012,0.0006097967,0.001024966,0.0006854106,0.003297342],"category_scores_gemma":[0.001051556,0.0003807897,0.0007503236,0.0006279309,0.0006477537,0.0007838244,0.0004005242,0.002549269,0.000466596],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001010276,"about_ca_system_score_gemma":0.001162236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008078607,"about_ca_topic_score_gemma":0.001907383,"domain_scores_codex":[0.9996595,0.00008332418,0.00001962021,0.00007380261,0.00004925319,0.0001145171],"domain_scores_gemma":[0.9995924,0.00009250554,0.00009079561,0.00005884919,0.00001952313,0.0001459316],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3355858,0.04392717,0.002913044,0.0007486664,0.000918717,0.000146016,0.0004021244,0.01304106,0.1358026,0.00267151,0.009259718,0.4545836],"study_design_scores_gemma":[0.3238927,0.5474662,0.01821464,0.00007075103,0.0008506803,0.0005459072,0.0001192526,0.01265255,0.07632107,0.001374005,0.01835732,0.0001349748],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898685,0.001815287,0.003391201,0.0003413017,0.0001964779,0.001423353,0.0005711045,0.0002467713,0.002146078],"genre_scores_gemma":[0.9911265,0.0008470279,0.004398562,0.0002257912,0.0001061788,0.001299373,0.0004696204,0.00005215592,0.001474732],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003297342,"threshold_uncertainty_score":0.01103067,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02243771064690426,"score_gpt":0.4925979184773803,"score_spread":0.4701602078304761,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}